Gambro acquires medical fluids plant in South Korea

Report this content

Gambro acquires medical fluids plant in South Korea Stockholm, Sweden, November 4, 2002 Gambro AB (Stockholmsbörsen: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, today announced that it has acquired a medical fluids production plant owned by the Korean life science company Green Cross Ltd. The plant is today a major supplier to Gambro in South Korea. The acquisition will provide local sourcing of concentrates for hemodialysis and a base for production of solutions for peritoneal dialysis for the Korean and Asian markets. Thereby Gambro is strengthening its position in Asia as a leading provider of products and systems for dialysis. The production unit has about 50 employees and will initially serve the Korean market. For further information please contact: Bo-Inge Hansson, President, Gambro Renal Products Asia, tel. +86-21-5046 1919 Bengt Modéer, Senior Vice President, Corporate Communications, tel. +46-8-613 65 33,+46-70-513 65 33 Pia Irell, Investor Relations Director, Corporate Finance, tel. +46-8-613 65 91, +46-70-513 65 91 Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology. Gambro Healthcare is one of the leading providers of kidney dialysis services in the world with more than 52,700 patients in 688 clinics worldwide. Gambro Renal Products comprises dialyzers, dialysis machines, blood lines and dialysis concentrates. Gambro BCT is the market leader in separation and handling of blood components. The group, with 2001 revenues of approximately SEK 27 billion (USD 2.7 billion), has 20,900 employees in some 40 countries. ------------------------------------------------------------ This information was brought to you by Waymaker The following files are available for download: